Jing Ji Guan Cha Bao·2025-10-24 06:30Group 1: China's Economic Policy and Foreign Investment - The Fourth Plenary Session of the 20th Central Committee of the Communist Party of China emphasized expanding high-level opening-up and creating a win-win cooperation environment, with a focus on maintaining a multilateral trade system and promoting international circulation [1] - By mid-2023, China had attracted a cumulative actual use of foreign capital amounting to $708.73 billion during the 14th Five-Year Plan period, with a year-on-year increase of 11.7% in newly established foreign-invested enterprises in the first half of 2025 [1][2] - The Ministry of Commerce reported that by the end of 2024, over 1.239 million foreign-invested enterprises had been established in China, with a cumulative actual use of foreign capital reaching 20.6 trillion yuan [2][6] Group 2: Multinational Corporations' Investments - Airbus inaugurated a second A320 series aircraft assembly line in Tianjin, which is expected to be fully operational by early 2026, reflecting the growing demand in the Chinese aviation market, projected to require 9,500 aircraft over the next 20 years [2][7] - Coca-Cola's recent financial report indicated a 14% increase in global sales of its sugar-free products, with the Asia-Pacific market being a significant growth driver [3] - Hilton Group opened the Waldorf Astoria Hotel in Shanghai, marking a milestone of over 888 hotels in China, and plans to double its hotel count in the country [5] Group 3: Industry Trends and Innovations - The report from the Ministry of Commerce indicated that high-tech sectors accounted for 43.7% of foreign investment in manufacturing by 2024, with foreign enterprises contributing nearly 50% to China's high-tech product exports [6][7] - The newly established Coca-Cola factory in Zhengzhou features advanced automation technologies, including a "smart robot picking" system, enhancing operational efficiency [6] - Boston Scientific launched its first manufacturing base in China, aiming to provide innovative medical products and strengthen local supply chains [8]